Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

FDA clears single-use, fully disposable endovascular robotic system
The new Liberty System allows users to remotely deliver and manipulate guidewires and catheters during peripheral endovascular procedures.
New York cardiologist headed to prison—DOJ says he paid for referrals, performed unneeded procedures
"Today’s sentence sends a deterrent message to doctors and the healthcare industry," according to a DOJ statement. "If you abuse patient trust for profit, you will face justice."
Abbott’s dissolving stent picks up a key approval
It's another big victory for Abbott's bioresorbable stent for BTK PAD.
FDA announces new recall of self-expanding stents due to risk of ‘serious harm’
The Class I recall includes more than 26,000 vascular stents from Boston Scientific. These devices have been linked to a risk of potential resistance when the stent delivery system is being withdrawn.
Cardiovascular device approvals continue to lead the FDA's Breakthrough Device Program
Cardiology is number one in FDA Breakthrough Device designations at 218, the highest number out of all other clinical categories. This includes 16 new devices cleared in the past year.

Regulatory roundup: FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical

It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance.

How to improve shared decision-making among vascular surgeons and their patients

Researchers introduced decision support tools to 13 different hospitals, tracking the overall impact on shared-decision making and patient knowledge.

Societies share new recommendations for endovascular specialists treating chronic limb-threatening ischemia

Given high mortality and a high threat of limb loss for CLTI patients, the statement aims to standardize core competencies and improve patient outcomes.

USPSTF updates its stance on aspirin use to prevent CVD, sees no benefit for patients 60 or older

These recommendations, the group emphasized, do not include patients with a history of CVD or those who are already taking aspirin for another reason.

4 support catheters receive FDA clearance for coronary use

The catheters were developed to be used during percutaneous coronary intervention procedures for coronary artery disease.

Asthma, other allergies linked to a higher risk of high blood pressure, coronary heart disease

The research was presented in South Korea at a two-day event hosted by the American College of Cardiology and Korean Society of Cardiology.

Deaths from MI, stroke and pulmonary embolism are down among kidney patients receiving dialysis

The new analysis, published in JAMA Network Open, focused on more than 220,000 dialysis patients treated from 1998 to 2015.

Virtual reality specialists launch new training solutions for endovascular surgery

The virtual reality training sessions were designed to feature "the same sights, sound and sensations a surgeon would encounter during real procedures."

Vascular & Endovascular

FDA clears single-use, fully disposable endovascular robotic system

New York cardiologist headed to prison—DOJ says he paid for referrals, performed unneeded procedures

Abbott’s dissolving stent picks up a key approval

FDA announces new recall of self-expanding stents due to risk of ‘serious harm’

Cardiovascular device approvals continue to lead the FDA's Breakthrough Device Program